Literature DB >> 1201667

Behavior of narcotics-addicted newborns.

M E Strauss, J K Lessen-Firestone, R H Starr, E M Ostrea.   

Abstract

The behavior of narcotics-addicted and nonaddicted newborns on the first 2 days of life was assessed with the Brazelton Neonatal Behavioral Assessment Scale. In addition to classic signs of narcotics abstinence, addicted infants were less able to be maintained in an alert state and less able to orient to auditory and visual stimuli. These deficits were especially pronounced at 48 hours of age. Addicted infants were as capable of self-quieting and responding to soothing intervention as normal neonates, although they were substantially more irritable. These characteristics and addicted infants' greater resistance to cuddling are discussed in terms of their potential impact on early infant-care-giver interaction.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1201667

Source DB:  PubMed          Journal:  Child Dev        ISSN: 0009-3920


  6 in total

1.  The Brazelton Neonatal Behavioral Assessment Scale (BNBAS).

Authors:  H Als; E Tronick; B M Lester; T B Brazelton
Journal:  J Abnorm Child Psychol       Date:  1977

2.  Neonatal behavior after drug dependent pregnancy.

Authors:  A L van Baar; P Fleury; S Soepatmi; C A Ultee; P J Wesselman
Journal:  Arch Dis Child       Date:  1989-02       Impact factor: 3.791

3.  Neonatal opiate withdrawal.

Authors:  R P Rivers
Journal:  Arch Dis Child       Date:  1986-12       Impact factor: 3.791

Review 4.  Behavior and development patterns in children born to heroin-addicted and methadone-addicted mothers.

Authors:  S M Hayford; R P Epps; M Dahl-Regis
Journal:  J Natl Med Assoc       Date:  1988-11       Impact factor: 1.798

5.  Perceptions and attitudes toward prenatal cocaine exposure in young children.

Authors:  E B Leckman; L C Mayes; H S Hodgins
Journal:  Child Psychiatry Hum Dev       Date:  2001

6.  Neonatal abstinence syndrome: Neurobehavior at 6 weeks of age in infants with or without pharmacological treatment for withdrawal.

Authors:  Nicole A Heller; Beth A Logan; Deborah G Morrison; Jonathan A Paul; Mark S Brown; Marie J Hayes
Journal:  Dev Psychobiol       Date:  2017-05-31       Impact factor: 3.038

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.